The high expression of IL-17 and IL-17RE in hepatocellular carcinoma may predict poor prognosis of patients with liver cancer (Liao et al., 2013), while decreased expression of interleukin-36α was associated with poor prognosis of patients with liver cancer (Pan et al., 2013). Here, IL17A is linked to hepatocellular carcinoma.